1.
De Novo Design and Molecular Dynamics Evaluation of AZ67-Derived Allosteric PFKFB3 Modulators for Anticancer Metabolic Drug Discovery. J. Can. Res. Updates. 2026;15(3):249-261. doi:10.30683/1929-2279.2026.15.23